San Diego, CA, United States of America

Huong T Dang

This inventor holds 3 USPTO granted patents and 6 published patent applications. Top assignee: Arena Pharmaceuticals, Inc.. Active years: 2010-2012.

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.2

ph-index = 1


Company Filing History:


Years Active: 2010-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Huong T Dang: Innovator in G Protein-Coupled Receptors

Introduction

Huong T Dang is a notable inventor based in San Diego, California. He has made significant contributions to the field of biochemistry, particularly in the area of transmembrane receptors. With a total of three patents to his name, his work focuses on the innovative use of nucleic acids and their applications in medical science.

Latest Patents

Huong T Dang's latest patents include groundbreaking inventions related to G protein-coupled receptors (GPCRs). One of his patents, titled "Nucleic acids encoding RUP3 and methods of using same," discloses important information about endogenous, human orphan GPCRs. Another patent, "Nucleic acids encoding the GPCR, RUP3, and methods of use thereof," further explores the applications of these receptors in various therapeutic contexts.

Career Highlights

Huong T Dang is currently employed at Arena Pharmaceuticals, Inc., where he continues to advance research in the field of pharmacology. His work has been instrumental in developing new methods for utilizing GPCRs, which are crucial for drug discovery and development.

Collaborations

Some of Huong T Dang's coworkers include Ruoping Chen and Chen Wang Liaw, who contribute to the collaborative efforts in their research projects. Their combined expertise enhances the innovative environment at Arena Pharmaceuticals.

Conclusion

Huong T Dang's contributions to the field of G protein-coupled receptors exemplify the impact of innovative research in biochemistry. His patents and ongoing work at Arena Pharmaceuticals highlight the importance of collaboration and creativity in scientific advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…